ACE-inhibitory activities
1. Introduction
Cardiovascular diseases (CVD) are a major health problem in the industrialized countries, representing the main cause of death in the world. It is estimated that 17 million people globally die of CVD every year and these diseases are responsible for more than half of all deaths in Europe [1]. Therefore, primary prevention is becoming an increasing part of public health strategies aimed at reducing societal burden due to CVD-related morbidity and mortality worldwide. There are several behavioural factors such as tobacco use, ethanol consumption, unhealthy diet and physical inactivity that can lead to hypertension, hyperlipidemia, diabetes, overweight and obesity, and thereby contribute to CVD development. The World Health Organisation emphasises the importance of improved nutrition as means of controlling the expected rise in global CVD incidence over the next decades.
Angiotensin I-converting enzyme (ACE: EC 3.4.15.1) is a peptidyldipeptide hydrolase that plays an important physiological role in both the regulation of blood pressure and cardiovascular function [2] through two different reactions. First, ACE catalyzes the hydrolysis of angiotensin I, an inactive decapeptide, to angiotensin II, a powerful vasoconstrictor and salt-retaining octapeptide. Thus, ACE-inhibition has a hypotensive effect. Secondly, ACE catalyzes the inactivation of the vasodilator bradykinin that regulates different biological processes including vascular endothelial nitric oxide (NO) release [3].
Oxidative stress has a well documented role in CVD development. Oxidative stress is defined as the situation characterized by increased generation of free radicals (reactive oxygen species, ROS), resulting in increased oxidative damage of biological structures. Within the cell, physiologic levels of some ROS are involved as key intermediates in signalling pathways to maintain basal cellular functions. In contrast, when ROS are generated in the absence of a physiological stimulus, small-molecule antioxidants are depleted, or antioxidant enzymatic systems are overwhelmed. This leads to a net increase in biologically active ROS and oxidant stress ensues. In blood vessels, oxidant stress has deleterious consequences for basal vascular function. Then, the cellular mechanisms that result in vascular redox imbalance leading to an increase in oxidant stress are implicated in the pathogenesis of vascular disease [4].
The search for dietary compounds that prevent the development of CVD is deemed crucial to tackle this major health problem worldwide, and recent observational studies and clinical trials have suggested that increased protein consumption, particularly from plant sources, might reduce blood pressure and prevent CVD. Recently, interest has been emerging to identify and characterize bioactive peptides from plant and animal sources. Bioactive peptides are considered specific protein fragments that are inactive within the sequence of the parent protein. After they are released they may exert various physiological functions. The type of bioactive peptides generated from a particular protein is dependent on two factors: (a) the primary sequence of the source protein and (b) the specificity of the enzyme(s) used to generate such peptides. The hydrolysis of plant proteins has led to the production of a variety of biologically active peptides, such as opioid, antihypertensive, antioxidative, immunomodulatory or antimicrobial peptides [5, 6]. Bioactivity of peptides depend on the structure, however, the structure activity relationship is not yet fully understood for all biological activities described. This present paper focuses on the peptides beneficial to CVD derived from plant proteins.
2. Biological activities of plant proteins
Potato tuber proteins are classified into three major groups: patatins, protease inhibitors, and other proteins. Patatin is the major storage protein and an allergen for some people. The second major potato tuber storage protein is a diverse group of low molecular weight protease inhibitors [7]. The majority of the patatin and proteinase inhibitor isoforms possess enzymatic and inhibitory activities, respectively, which might be of physiological relevance. Activities are associated with the defense mechanisms of potato against pathogens and they inhibit a variety of proteases and some other enzymes, for example invertase [8]. Low molecular weight antimicrobial potato peptides from potato tubers have recently been reported to exhibit antibiotic/antifungal activity also against human pathogenic fungal and microbial strains [9]. The broad phospholipase activity of patatin has been characterized and documented rather extensively [10, 11]. The results indicate that the patatin-related enzymes are, in addition to fat metabolism, involved in the stress responses and signal transduction in the potato tubers. Patatin has also been shown to possess antioxidant or antiradical activity. Liu and colleagues [12] found that purified patatin exert antioxidant or antiradical activity in various
The protein content of defatted rapeseed meal is high, approximately 32%, making it a potential food ingredient. Rapeseed protein has recently been demonstrated to be of high nutritional value in human subjects and substituting Cys-rich rapeseed protein, for milk protein prevented the early onset of insulin resistance, similar to those achieved by manipulating dietary fat and carbohydrates in a rat model [16, 17]. Flaxseed and its defatted meal contain high amounts of proteins, which are comparable in amino acid composition to food proteins like soy, with a preponderance of basic and branch-chain amino acids. The high Cys and Met content can boost the body’s antioxidant levels, potentially stabilising DNA during cell division and reducing risk of certain forms of colon cancer [18]. Yet, there are only few studies examining rapeseed and flaxseed meals as source of bioactive peptides to enhance the value of these rapeseed and flaxseed industry by-products.
Legumes could represent valuable tools to prevent CVD, in addition to constitute an important source of dietary proteins (~18-40 %), dietary fibre, minerals and vitamins. Epidemiological studies have provided consistent evidence of the inverse relationship between legume consumption and the incidence of CVD. The majority of studies that have evaluated the hypocholesterolemic effects of legume consumption examined soybeans [19]. In addition, the meta-analysis showed that diet rich in legumes, such as a variety of beans, peas, and some seeds other than soy decreases total and low-density lipoprotein (LDL) cholesterol [20]. Different legumes have been identified as sources of ACE-inhibitory and antioxidative peptides, mainly soybean [21-24], chickpea and pea [25-28].
Cereal grains contain relatively little protein compared to legume seeds, with an average of about 10–12% of dry weight. Storage proteins account for about 50% of the total protein in mature cereal grains and have important impacts on their nutritional quality for humans and livestock and on their functional properties in food processing. Proteins can be separated into albumin, globulin, prolamin (hordein) and gluten fractions as described by [29]. The prolamins are characterized by their high content of Pro and Glu and low content of Lys and Trp. Alcohol-soluble endosperm proteins (prolamins) from some cereals (e.g. wheat, barley, and rye) give origin upon proteolytic digestion to biologically active antinutritional peptides able to adversely affect
2.1. Production of peptides
ACE-inhibitory peptides have been produced by enzymatic hydrolysis and microbial fermentation of food proteins. In addition, solvent extraction has been used to isolate ACE-inhibitory activity from plant materials, such as mushrooms, broccoli and buckwheat [6]. The ACE-inhibitory potency is expressed as the IC50 value (inhibitor concentration leading to 50% inhibition), being used to estimate the effectiveness of different hydrolysates and peptides. The most common way to produce bioactive peptides is through enzymatic hydrolysis of whole protein molecules. The specificity of enzyme and process conditions influence the peptide composition of hydrolysates and thus their activities.
Generally, enzymatic hydrolysis is widely applied to upgrade functional features (such as emulsifying properties of hydrolysed protein) and nutritional properties of proteins [34-36]. It has been reported that additional advantage of hydrolysis can be the development of hydrophobicity since proteolysis unfolds the protein chains. The cleavage of peptide bonds enhances levels of free amino and carboxyl groups resulting in enhanced solubility. Therefore, hydrolysis can increase or decrease the hydrophobicity, which mostly depends on the nature of the precursor protein and molecular weight of the generated peptides [34]. Moreover, hydrolysis leads to production of small bioactive peptides [35] and bitterness of peptides of below 1000 Da is much less than fractions with a higher molecular mass [36]. However, it has been reported that extensive hydrolysis could adversely affect functional properties of peptides [37]. Some factors to consider in producing bioactive peptides include hydrolysis time, degree of hydrolysis of the proteins, enzyme–substrate ratio, and pre-treatment of the protein prior to hydrolysis. For example, thermal treatment of proteins can enhance enzymatic hydrolysis [38] possibly by increasing enzyme–protein interactions due to thermal-induced unfolding of the proteins.
According to the literature, enzymatic hydrolysis has been the main process for producing ACE-inhibitory and antioxidative peptides from food proteins. Use of exogenous enzymes is preferred in most cases over the autolytic process (i.e., use of endogenous enzymes present in the food source itself), due to the shorter time required to obtain similar degree of hydrolysis as well as better control of the hydrolysis to obtain more consistent molecular weight profiles and peptide composition [39-45]. Industrial food-grade proteinases such as Alcalase, Flavourzyme, and Protamex derived from microorganisms, as well as enzymes from plant (e.g. Papain) and animal sources (e.g., pepsin and trypsin), have been widely used in producing ACE-inhibitory and antioxidative peptides. The serine type endo-protease Alcalase, has produced the highest ACE-inhibitory activities
Alcalase digests of rapeseed, canola, flaxseed, sunflower seed protein, legumes as well as and mung and chick beans showed high potency for ACE inhibition [41, 43-48]. Moreover, Alcalase digestion increased the ACE inhibition of the protein-rich by-product fraction from potato starch industry, potato tuber liquid fraction [13]. The IC50 -values were ranged between 0.020 and 0.64 mg protein/ml, which are similar to those reported for milk whey and casein hydrolysates [5, 41, 45-47,49]. Mäkinen and colleagues [50] reported that
Identified peptides | |||||||
Sweetpotato tuber protein isolate | Thermoase PC 10F, Protease S & Proleather FG-F | 0.018 | ITP IIP GQY STYQT | 9.5 80.8 52.3 300.4 | 500 mg/kg hydrolysate, oral, SHR | -30 after 8 h | [121] |
Sweetpotato tuber defensin | Trypsin | 0.190 | GFR FK IMVAEAR GPCSR CFCTKPC MCESASSK | 94.25 265.43 84.12 61.67 1.31 75.93 | [118] | ||
Sweet potato tuber Thioredoxin h | Trypsin | 0.152 | EVPK VVGAK FTDVDFIK MMEPMVK | 1.73 1.14 0.42 1.03 | [119] | ||
Sweetpotato tuber Trypsin inhibitor | Pepsin | 0.188 | HDHM LR SNIP VRL TYCQ GTEKC RF VKAGE AH KIEL | 276.2 746.4 228.3 208.6 2.3 275.8 392.2 141.56 523.5 849.7 | [120] | ||
Yam tuber | Powdered yam product, alcohol-insoluble-solids Water extract (15% protein) Heat treated (90°C) water extract Dioscorin, lyophilized yam powder Storage protein ion-exhange chromato-graphy Pepsin hydrolysate | ND | 60 mg/kg oral, SHR 154 mg/kg oral, SHR 154 mg/kg oral, SHR 140 mg daily oral, human 40 mg/kg oral, SHR 40 mg/kg oral, SHR | -32.4 after6 h -30.3 after4 h -23.87 after4 h -6.52 after 2 weeks -27.7 after 9 days -32.8 after 8 hours | [123] [86] [175] [122] [122] | ||
Potato tuber | Autolysed protein extract Alcalase digest of potato tuber liguid fraction | 0.36 0.018 | [50] [13] | ||||
Water extract (rich in proline) | 127 | 200 mg/kg oral, SHR | -25 after 0.5 and 1 h | [124] | |||
Rapeseed protein | Pepsin Subtilisin | 0.16 0.16 | VWIS VW IY RIY | 30 1.6 3.7 28 | 500 mg/kg hydrolysate, 12.5 mg/kg 7.5 mg/kg 7.5 mg/kg 7.5 mg/kg oral, SHR | -6.8 after 4h -15.5 after 4h -12.5 after 2 h -10.8 after 2 h -9.8 after 2 h -11.3 after 4h | [125] |
Rapeseed protein | Alcalase Peptide fraction from affinity purification Alcalase | 0.038 0.25x10-3 0.020 | [45] [47] | ||||
Canola meal, defatted | Heat treatment and Alcalase | 0.027 | VSV FL | 0.15 1.33 | [46] | ||
Flaxseed protein | Trypsin & Pronase cationic peptide fraction | 0.4 | QGR RW SVR GQMRQPIQQQG ASVRT DYLRSC ARDLPGQ RDLPG RGLERA TCRGLERA | 200 mg/kg hydrolysate, oral, SHR | -17.9 after2 h | [44] | |
Flaxseed protein | Gastrointestinal | 0.040 | WNI/LNA NI/LDTDI/L | [127] | |||
Sunflower protein | Alcalase Peptide fraction from affinity purification | 0.062 1.18x10-3 | [61] | ||||
Pea protein | Gastrointestinal digest | 0.070 | 50 mg/kg intravenous, SHR | -44, transient and sharp reduction | [144] | ||
Pea protein isolate | Thermolysin, 3kDa MWCO permeate | ND | 200 mg/kg oral, SHR 25-30 g/day oral, Han:SPDR-cy rat 3g/day oral, Human, consumption | -19 after 4h -30 at weeks 7 and 8 -6 after 3 weeks | [143] | ||
Chick pea protein | Alcalase | Peptide fractions | 0.103- 0.117 mg/ml | [41] | |||
Chick pea legumin | Alcalase | Peptide peaks | 0.011-0.021 mg/ml | [43] | |||
Common beans Pinto beans Green lentils | Heat treatment and | 0.78-0.83 0.15-0.69 0.008-0.89 | [131] | ||||
Red and green lentil protein | 0.053- 0.190 | [64] | |||||
Mung bean protein | Alcalase, 6kDa MWCO permeate | 0.64 | KDYRL VTPALR KLPAGTLF | 26.5 82.4 13.4 | 600 mg/kg oral, SHR | -30.8 after6 h | [48] |
Mung bean sprout | Raw sprout extract Dried sprout extract Pepsin, trypsin and chymotrypsin | 600 mg/kg intragastric, SHR | -41 after 6 h -24 after 3 h -29 after 3 h | [142] | |||
Soy protein | Alcalase | 0.065 | DLP DG | 4.8 12.3 | [39] | ||
Soybean | Fermentation | 0.45 | AW GW AY SY GY AF VP AI VG | µg/ml 0.03 0.05 0.07 0.10 0.19 0.48 0.69 1.1 | Diet contained 10% v/w of fermented soy product oral, SHR | -20 after 11 week | [184] |
Rye | Sourdough | VPP IPP LQP LLP | 9 5 2 57 | [149] | |||
Rice | Alcalase | 0.14 | TQVY | 18.2 | 600 mg/kg hydrolysate 30 mg peptide/kg SHR, oral | -25.6 after6 h -40 after 6 h | [153] |
Maize, α-zein | Thermolysin | LRP LSP LQP | 0.29 1.7 2.0 | Peptide (LRP) 30 mg/kg SHR, intravenous | -15 2 min after injection | [31] | |
Wheat bran | Autolysis | 0.08 | LQP IQP LRP VY IY TF | peptide-fraction 0.14 mg/ml | 10 mg/ml oral, SHR | -45 after 2 h | [185] [186] |
autolysis of protein isolates from the potato tuber tissue enhances ACE-inhibition which may be due to the native proteolytic activity of potato tuber proteins.
Peña-Ramos and Xiong [51] used different enzymes to produce hydrolysates from native and heated soy protein isolates. They reported that using different enzymes resulted in the formation of a mixture of peptides with different degrees of hydrolysis and accordingly different ranges of antioxidant activity. It has been found that antioxidant activity of Alcalase derived hydrolysates is higher than that of other hydrolysates [52-54]. It is also reported that peptides produced by Alcalase have diverse biological activities, including antioxidant activity [55]. In comparison to other proteases, it provided higher yields of antioxidative peptides and develops shorter peptides. Udenigwe and colleagues [55] observed that release of radical scavenging peptides depends on the specificity of protease used in hydrolysis. In another study, flaxseed protein was treated with thermolysin followed by pronase to produce antioxidant peptides [42]. Moreover, pepsin, pancreatin, neutrase and esperase have been used to produce antioxidative hydrolysates and peptides [13, 42, 51, 56, 57].
Simulated gastrointestinal enzymatic process has also been used to mimic normal human digestion of proteins to evaluate the possibility of releasing potent bioactive peptides after normal consumption of food proteins. The combination of pepsin-trypsin-chymotrypsin or pepsin-pancreatin has been used to simulate the gastrointestinal degradation of proteins in humans [58]. Pepsin treatment alone cannot effectively elicit ACE-inhibitory peptides from buckwheat protein, while this enzyme followed by chymotrypsin and trypsin lead to a significant increase in ACE-inhibitory activity [59]. In some studies, plant protein hydrolysates generated during pepsin digestion have potent ACE-inhibitory peptides. Lower ACE-inhibitory activity was found after subsequent digestion with pancreatin, suggesting that the active components were hydrolyzed [60, 61]. For the pea proteins, high ACE-inhibitory activity is reached at the early stage of pepsin hydrolysis and the level is maintained during the small intestine phase using trypsin-chymotrypsin treatment [62]. While digestion of red lentils with trypsin showed moderate ACE inhibition (IC50 value of 0.44 mg/ml), addition of pepsin and chymotrypsin clearly improved it (IC50 of 0.09 mg/ml) [63, 64].
Careful choice of suitable enzymes and digestion conditions such as optimal temperature, degree of hydrolysis and enzyme-substrate ratio, as well as the control of hydrolysis time, are crucial for obtaining protein hydrolysates with desirable functional and bioactive properties. Hydrolysis can be performed by conventional batch hydrolysis or by continuous hydrolysis using ultrafiltration membranes. The traditional batch method has several disadvantages, such as the relatively high cost of the enzymes and their inefficiency compared to a continuous process, as noted in numerous studies [65, 66]. The hydrolysis process is feasible to scale-up production of peptides from laboratory scale to pilot and industrial plant scales with conserved peptide profiles and bioactivity of the resulting products [67]. The crude protein hydrolysate may be further processed, for example by passage through ultrafiltration membranes, in order to obtain a more uniform product with the desired range of molecular mass [68]. Alcalase hydrolysate from soy isolate was ultrafiltrated with 1-30 kDa membranes and ACE-inhibitory activities were analysed. The IC50-values for 1 kDa and 10 kDa permeates were almost the same, 0.080 and 0.078 mg/ml, respectively, but recovery yield of 10 kDa permeate was much higher than that of 1 kDa permeate [69]. Ultrafiltration membrane reactors have been shown to improve the efficiency of enzyme-catalysed bioconversion, to increase product yields, and to be easily scaled up. Furthermore, ultrafiltration membrane reactors yield a consistently uniform product with desired molecular mass characteristics [65, 68]. Low molecular mass cut-off membranes are useful for concentrating bioactive peptides from the higher molecular mass components remaining, including undigested polypeptide chains and enzymes. Other techniques such as nanofiltration, ion-exchange membranes, or column chromatographic methods can be used in further concentration and purification of the peptides [70].
A number of studies have shown that antihypertensive peptides are liberated during fermentation of milk. Fermented milk products prepared using different strains of lactic acid bacteria have been found to exert antihypertensive and antioxidative activities [71, 72]. Moreover, several antioxidative and ACE-inhibitory peptide sequences have been identified from fermented milk [73]. Only few experimental investigations to produce these compounds by fermentation of plant proteins have been reported. Fermentation of rapeseed and flaxseed proteins with
2.2. Structure-activity relationship
ACE-inhibitory peptides are generally short sequences often carrying polar amino acid residues like Pro. This is in agreement with the results of Natesh and co-workers [81] who showed that the active site of ACE cannot accommodate large peptide molecules. The C-terminal tripeptide strongly influences the binding of substrate or a competitive inhibitor to ACE. Many ACE-inhibitory peptides identified from different food sources, structure–activity studies indicated that C-terminal tripeptide residues play a predominant role in competitive binding to the active site of ACE. It has been reported that this enzyme prefers substrates or inhibitors containing hydrophobic (aromatic or branched side chains) amino acid residues at each of the three C-terminal positions. The most effective ACE-inhibitory peptides identified contain Tyr, Phe, Trp, and/or Pro at the C-terminal. In addition, structure–activity data suggests that the positive charge of Lys (ε−amino group) and Arg (guanidine group) as the C-terminal residue may contribute to the inhibitory potency [82-84]. Quantitative structure–activity relationship (QSAR) modelling was used to develop statistical computer models potentially capable of identifying ACE-inhibitory peptides based on structure–activity data [85]. A relationship was found between hydrophobicity and positively charged amino acid in C-terminal position, size of amino acid next to C-terminal position and ACE inhibition of peptides up to six amino acids in length. Moreover, no relationship between N-terminal structure and inhibition activity was found.
The exact mechanism underlying the antioxidant activity of peptides has not fully been understood, as various studies have displayed that they are inhibitors of lipid peroxidation, scavengers of free radicals and chelators of transition metal ions [86, 87]. In addition, it has been reported that antioxidative peptides keep cells safe from damage by ROS through the induction of genes [88]. Antioxidative properties of the peptides are more related to their composition, structure, and hydrophobicity. Tyr, Trp, Met, Lys, Cys, and His are examples of amino acids that cause antioxidant activity. Amino acids with aromatic residues can donate protons to electron deficient radicals. This property improves the radical scavenging properties of the amino acid residues [89, 90]. It is proposed that the antioxidative activity of His containing peptides is in relation with the hydrogen donating, lipid peroxyl radical trapping and/or the metal ion chelating ability of the imidazole group [87, 91]. On the other hand, SH group in Cys has an independently crucial antioxidant action due to its direct interaction with radicals [92]. In addition to the amino acid composition, their correct position in peptide sequence plays an important role in antioxidative properties of peptides. Chen and colleagues [93] designed 28 synthetic peptides following the structure of an antioxidative peptide (Leu-Leu-Pro-His-His) from digestion of soybean protein conglycinin. According to the results, Pro-His-His sequence displayed the greatest antioxidative activity among all tested peptides. The antioxidant activity of a peptide was more dependent on His-His segment in the Leu-Leu-Pro-His-His-domain and its activity was decreased by removing a His residue from the C-terminus. Moreover, substitution of L-His by D-His in a peptide leads reduction of activity [93]. They concluded that the correct position of imidazole group is the key factor influencing the antioxidant activity. Saito and co-workers [94] also studied antioxidative activity of peptides created in two tripeptide libraries. According to their results, for the 114 peptides containing either His or Tyr residues, tripeptides containing two Tyr residues showed higher activity in the linoleic acid peroxidation system than tripeptides containing two His residues. Further, Tyr-His-Tyr showed strong synergistic effects with phenolic antioxidants. It has been shown that certain amino acids can exert higher antioxidative properties when they are incorporated in dipeptides [95] and some peptide bond or its structural conformation can reduce the antioxidant activity of the constituent amino acids [96].
2.3. In vitro and in vivo activity
The search for
Specific assays have not yet been developed or standardized to measure the antioxidative capacity of peptides or peptide mixtures. Therefore, assays that are commonly used for measuring antioxidative capacity of non-peptidic antioxidants have been used in the literature to measure the antioxidative capacity of peptides as well. Due to the complexity of oxidative processes occurring in food or biological systems as well as the different antioxidative mechanisms by which various compounds may act, finding one method that can characterize the overall antioxidative potential of food is not an easy task. Nevertheless, methods such as the Trolox equivalent antioxidant capacity (TEAC) assay, oxygen radical absorbance capacity (ORAC) assay, and the total radical-trapping antioxidant parameter (TRAP) assay have been widely reported in the literature for measuring antioxidative capacity of food and biological samples [106, 107]. Commonly used assays include measuring the inhibition of lipid peroxidation in a linoleic acid model system and the capacity to scavenge the 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)/2,2-Diphenyl-1-picrylhydrazyl (ABTS/DPPH) radicals.
The antihypertensive effects can be assessed by
2.4. ACE-inhibitory and antioxidant peptides
2.4.1. Potato and other root crops
During the last decade the
Sweet potato proteins defensin and thioredoxin h2 which were overproduced in
The protein-rich by-product fraction from potato (
Recently, antihypertensive effects of some tuber plant –derived protein digests have been evaluated
2.4.2. Oil seed plants-derived peptides
According to the published data, enzymatic hydrolysis is required to release antihypertensive peptides from oil seed plant proteins. Only few peptide sequences have been identified from oil seed plants. Four ACE-inhibitory peptides were isolated from the rapeseed subtilisin digest of which Ile-Tyr and Arg-Ile-Tyr can be found in the primary structure of napin and Val-Trp and Val-Trp-Ile-Ser exist in the primary structure of cruciferin and ribosomal protein, respectively. Among the peptides isolated, Ile-Tyr and Val-Trp can be considered true ACE-inhibitors because IC50 values for these peptides before and after pre-incubation with ACE were found to be the same. Val-Trp-Ile-Ser is a pro-drug type ACE-inhibitor, as pre-incubation with ACE of Val-Trp-Ile-Ser intensified inhibitory activity of this peptide [125]. In addition, to these rapeseed peptides, two peptide sequences with high ACE-inhibitory capacity were identified from canola meal hydrolysed with Alcalase, Val-Ser-Val and Phe-Leu, located in the primary structure of canola napin and cruciferin proteins [46]. Low-molecular weight cationic peptide fractions from flaxseed protein hydrolysed by Alcalase or thermolysin showed concentration dependent ACE-inhibition (IC50 0.0275-0.151 mg/ml) [126]. The Alcalase cationic peptide and thermolysin hydrolysate showed mixed type inhibition of ACE activity. Several peptides were detected in a cationic peptide fraction of a trypsin & Pronase digest of flaxseed, which showed moderate ACE inhibition
Despite the high
Peptide fraction from the enzymatic digest of flaxseed protein was recently reported to possess hypotensive activity in SHR [44]. An Arg-rich peptide fraction was produced from flaxseed protein using trypsin and pronase and by subsequent concentration with combined electrodialysis and ultrafiltration. The hypotensive effect of the flaxseed derived Arg-rich peptide fraction was tested on SHR and the effects were compared to the effects of inherent flaxseed protein isolate and amino acid form of Arg. The maximum hypotensive effect of the cationic peptide fraction was observed already 2 h after oral administration while the amino acid form of Arg showed lower hypotensive activity, -10.3 mmHg. On the other hand, the flaxseed protein isolate exhibited a slow-acting hypotensive effect with maximum of -18.4 mmHg (SBP) at 6 h after the administration. The hypotensive effect of the Arg-rich peptide fraction was longer-lasting when compared to the free amino acid form of Arg and the authors suggested that this might be related to more efficient absorption of peptides and the ability of peptides to translocate directly into the cells, obviating the need for transporters. The observed hypotensive activity of flaxseed protein and peptide fraction could be due to vasodilatory activity of NO synthesized from the Arg through the L-Arg-NO pathway in the vascular endothelium, or ACE- and renin-inhibition observed
2.4.3. Legume derived peptides
Several enzymes have been used to produce pulse protein hydrolysates having bioactive properties. It has been suggested that hydrolysates of chickpea legume and mung bean obtained by Alcalase treatments are good sources of ACE-inhibitory peptides [43, 48]. Potential ACE-inhibitory potencies of common dry beans, dry pinto beans and green lentils increased during
Enzymatic hydrolysate of soy protein showed a moderate ACE-inhibitory activity (0.034 mg/ml) [39] as compared with values reported ranging from 0.021 to 1.73 mg/ml [5, 6, 49, 70]. Lo and co-workers [134] applied the dynamic model for the
Pea protein hydrolysates by thermolysin contained low molecular weight (<3 kDa) peptides with various antioxidant activities that were dependent on the amounts of hydrophobic and aromatic amino acid constituents [135] (Table 2). Peptide fractions with the least cationic property had significantly stronger scavenging activity against DPPH and H2O2. Generally, the scavenging of O2˙− and H2O2 was negatively related with the cationic property of the peptide fractions [136]. Chick pea hydrolysate with antioxidant activities was prepared from chickpea protein isolates by Alcalase. This hydrolysate was separated with Sephadex G-25. Four fractions were obtained, and fraction IV had the highest antioxidant activities assayed by free radical scavenging effects [137]. The active peptide was identified as Asn-Arg-Tyr-His-Glu. This peptide quenched the free radical sources DPPH, hydroxyl, and superoxide free radicals. Furthermore, the inhibition of the peptide on lipid peroxidation was greater than that of α-tocopherol [57].
Different hydrolysis conditions of soy protein isolates have resulted in peptide mixtures with different antioxidant properties. Native and heated soy protein isolate hydrolysed with different enzymes resulted in different degree of hydrolysis ranging from 1.7-20.6 with antioxidant activity ranging from 28% to 65% [138]. Zhang and coworkers [139] used three microbial proteases to produce hydrolysates with degree of hydrolysis values from 13.4% to 26.1% and with different oxygen radical absorbance capacity (ORAC), DPPH-radical
Potato liquid fraction | ABTS+- scavenging | Not specified | [13] | |
Potato protein concentration | ABTS+-- scavenging Emulsion oxidative stability | Alcalase | SSEFTY IYLGQ | [14] |
Soybean proteins | Liposome oxidizing system | Not specified | [51] | |
Soybean protein b-conglycin | Linoleic acid peroxidation system | Protease M, Protease N, Protease P, | VNPHDHQN LVNPHDQN LLPHH LLPHHADADY VIPAGYP LQSGDALRVPSGTTYY | [141] |
Yellow pea seed protein | Radical (DPPH, O2-, H2O2) scavenging and inhibition of linoleic acid oxidation | Thermolysin | NRYHE | [135] |
Barley glutelin | Radical scavenging capacity (DPPH/O2-/OH-), Fe2+-chelating effect and reducing power | Alcalase | QKPFPQQPPF PQIPEEF LRTLPMSVNVPL | [54] |
Wheat gluten | Linoleic acid peroxidation system | Pepsin | LQPGQGQQG AQIPQQ | [56] |
Rice endosperm protein | O2-, OH and DPPH radical sacavenging capacity, Linoleic acid peroxidation system | Alcalase, Chymotrypsin, | FRDEHKK KHNRGDEF | [151] |
scavenging activities as well transition metal chelating activities. Chen and coworkers [140] isolated 6 antioxidative peptide fragments from the digests of β-conglycinin, a main soybean protein component, by using protease S from
Pea and mung bean protein digests have been reported to possess antihypertensive activity in SHR [48, 142]. Mung bean protein hydrolysate prepared with alcalase decreased significantly SBP (-30.8 mmHg) of SHR 6 h after single oral administration at a dose of 600 mg/ml. The blood pressure-lowering effect continued for at least 8 h, and the blood pressure returned to initial levels at 12 h after administration [48]. Single administration of mung bean raw sprout extract (at dose of 600 mg/kg) reduced significantly SBP (-40 mmHg) 6 h after administration. Plasma ACE activities in the treated rats also decreased (0.007 Unit/ml). Long-term intervention (1 month) test showed that blood pressure in the treated animals fluctuated according to the treatments. While raw sprout extract showed effective results after 1 week of intervention, dried sprout extracts did not have significant effects until 2 weeks [142]. Pea protein hydrolysate was made by thermolysin action followed by membrane filtration. Oral administration of the pea protein hydrolysate, containing <3 kDa peptides, to SHR at doses of 100 and 200 mg/kg body weight led to a lowering of SBP, with a maximum reduction of 19 mmHg at 4 h. In contrast, orally administered unhydrolysed pea protein isolate had no blood pressure reducing effect in SHR, suggesting that thermolysin hydrolysis may have been responsible for releasing bioactive peptides from the native protein [143]. Pea protein peptides from
2.4.4. Cereals
The seed storage proteins of wheat, barley, rye, and oats contain known ACE-inhibitory di- and tripeptides in their primary structures. Barley and barley by-products extract possesses a biological activity such as free radical scavenging activity, tyrosinase, xanthin oxidase, and ACE-inhibition effect [145]. Hydrolysates of barley prolamin fraction exhibited the highest antioxidant and ACE-inhibitory activity compared to other protein fractions and protein isolate. Moreover, positive correlations were obtained between antioxidant and ACE-inhibitory activity and the degree of hydrolysis of hydrolysed protein fractions and protein isolate [146].
The computer analysis of amino acid sequences of wheat gliadins made by means of BIOPEP database [147] showed the presence of fragments that are homological with the sequences regarded as antihypertensive peptides. They were: Leu-Gln-Pro (α-, β- and γ-gliadins), Pro-Tyr-Pro (α-, β- and γ-gliadins), Ile-Pro-Pro (α-and β-gliadins), Leu-Pro-Pro (γ-gliadins) and Leu-Val-Leu (γ-gliadins). Bioinformatic analysis of cereal proteins sequences revealed that particularly four tripeptides with known ACE-inhibitory activity, Leu-Gln-Pro, Val-Pro-Pro, Ile-Pro-Pro, and Leu-Leu-Pro, are frequently encrypted in the primary structure of rye secalin, wheat gluten, and barley hordein. Sourdoughs fermented with different strains showed different concentrations of Leu-Gln-Pro and Leu-Leu-Pro. These differences corresponded to strain-specific differences in endopeptidase (PepO) and aminopeptidase (PepN) activities. The highest levels of peptides Val-Pro-Pro, Ile-Pro-Pro, Leu-Gln-Pro, and Leu-Leu-Pro, 0.23, 0.71, 1.09, and 0.09 mmol/ kg dry matter (DM), respectively, were observed in rye malt: gluten sourdoughs fermented with
Barley glutelin possess high hydrophobic amino acid content and enzymatic release by Alcalase produced peptides that had antioxidant capacity. Large size peptides possessed stronger DPPH scavenging activity and reducing power, whereas small-sized peptides were more effective in Fe2+ and hydroxyl radical scavenging activity [54]. Pepsin hydrolysis of by-product of the wheat starch industry has shown antioxidant properties. Especially ultrafiltration produced fraction showed strong inhibition of the autoxidation of linoleic acid and scavenging activity of DPPH, superoxide and hydroxyl free radicals. The molecular weight distribution ranged from 0.1-1.7 kDa and high content of total hydrophobic amino acid was found in the active fraction [150]. Rice endosperm protein was, respectively, digested by five different protease treatments (Alcalase, chymotrypsin, Neutrase, Papain and Flavorase), and Neutrase produced the most desirable quality of antioxidant peptides. Two different peptides showing strong antioxidant activities were isolated from the hydrolysate using consecutive chromatographic methods. Especially, Phe-Arg-Asp-Glu-His-Lys-Lys significantly inhibited lipid peroxidation in a linoleic acid emulsion system more effectively than α-tocopherol [151].
The Alcalase-generated rice hydrolysate showed ACE-inhibitory activity with an IC50 value of 0.14 mg/ml. A potent ACE-inhibitory peptide with the amino acid sequence of Thr-Gln-Val-Tyr (IC50 of 18.2 μM) was isolated and identified from the hydrolysate. Single oral administration of the hydrolysate (600 mg/kg) and Thr-Gln-Val-Tyr (30 mg/kg) showed significantly decreased blood pressure in SHR, -25.6 and -40 mmHg SBP, respectively, after 6h [152]. Three strong ACE-inhibitors with the Leu-Arg-Pro, Leu-Ser-Pro and Leu-Gln-Pro sequences were isolated from maize α-zein hydrolysed with thermolysin. After intravenous administration of these peptides (30 mg/kg body weight), SBP was found to decrease up to a maximum of 15 mmHg [31]. Moreover, a tripeptide (Ile-Val-Tyr) isolated from wheat germ hydrolysate reduced MAP of 19.2 mmHg at dose of 5 mg/ml in SHR [153].
3. Bioavailability
Bioavailability is a major issue when establishing correspondence between
Study of intestinal absorption
Fujita and colleagues [166] established a bioavailability factor in relation to antihypertensive activity and ACE inhibition mechanism. The classification is based on inhibitor type and substrate type, the possible conversion of peptides by ACE into peptides with weaker activity and pro-drug type inhibitors, or possible conversion of peptides into true inhibitors by ACE or gastrointestinal proteases. A delayed antihypertensive effect is characteristic for pro-drug type peptides as they need to degrade further to reach the final active form [167, 168]. For instance, flaxseed protein showed pro-drug type characteristics compared to hydrolysed cationic peptide fraction [126]. The protein fraction showed a delayed hypotensive effect in SHR comparable to captopril (3 mg/kg body weight) and the effect was more sustained than the effect of the digested peptide fraction. The slow-acting character of the protein fraction was expected since the digestion of the proteins. Anyhow, more research is needed to identify the active peptide sequences released in the digestive tract and to evaluate the bioavailability of these peptides.
It can be deduced due to the incomplete bioavailability of peptide following oral ingestion, a peptide with pronounced antioxidant activity
The improvement and optimization of bioavailability of antihypertensive peptides have gained a great interest during the last decade. The improvement of limited absorption and stability of peptides has been a goal when evaluating their effectiveness. For example, some carriers interact with the peptide molecule to create an insoluble entity at low pH, which later dissolves and facilitates intestinal uptake, by enhancing peptide transport over the non-polar biological membrane [169]. Bioavailability of bioactive tri-peptides (Val-Pro-Pro, Ile-Pro-Pro, Leu-Pro-Pro) was improved by administering them with a meal containing fibre, as compared to a meal containing no fibre. High methylated citrus pectin was used as a fibre [170]. Among drug delivery systems, emulsions have been used to enhance oral bioavailability or promoting absorption through mucosal surfaces of peptides and proteins [169]. Individually, various components of emulsions have been considered as candidates for improving bioavailability of peptides. Anyhow, it seems that no general strategy for improving bioavailability of antihypertensive peptides exists and due to the number of processes involved and different characteristics of peptides depending on the sequence each case must be studied. Many strategies are currently demonstrated for enhancing bioavailability [171], among them microencapsulation for controlled release of the active compounds, stabilization of the active molecules to improve transportation through the intestinal barrier and provide resistance against degradation, and development of highly stabile peptide analogues [172-174].
4. Health benefits
ACE-inhibitory peptides have been studied extensively in the past two decades and ACE-inhibition is the main mechanism concerning bioactive peptides with proven antihypertensive effects. ACE is a constituent enzyme of the Renin-Angiotensin-Aldosterone System (RAAS), which is a crucial regulator in human physiology. It controls blood pressure, fluid and electrolyte balance and affects the heart, vasculature and kidney [2]. Among the food-derived ACE-inhibitory peptides milk-derived peptides are the most extensively studied. The relevance of vegetable proteins as a source of antihypertensive peptides is increasing and several
Furthermore, related to the RAAS, plant derived ACE-inhibitory peptides have been reported to possess inhibition activity against renin, the first and rate-determining enzyme in RAAS [2]. The inhibition of renin is being suggested as a major alternative in hypertension prevention. The first direct renin-inhibitor, aliskiren, is currently under phase III trials to evaluate its potential as an antihypertensive drug [176]. Thermolysin digest of pea protein decreased remarkably the renal expression of renin mRNA levels
Opioid receptors are involved in various physiological phenomenons, e.g. in the regulation of blood pressure and circulation, and these receptors are related to the antihypertensive properties of some food derived peptides. Other vasodilatory substances, such as ET-1, have also been suggested to be involved in the antihypertensive effects of food-derived peptides [173, 178, 179]. However, peptide sequences derived specifically from plant proteins inducing endothelial NO liberation have not been reported this far. A cationic Arg-rich peptide fraction from flaxseed, which possessed hypotensive effects in SHR, was suggested to mediate blood pressure through vasodilatory activity of NO synthesized from Arg. The observed effect might also be due to ACE- and renin-inhibition and in-depth research is needed to measure the renin and ACE protein levels and activities in SHR tissues and plasma and to specify the prior mechanism of antihypertensive action [44].
Calmodulin (CaM) –dependent cyclic nucleotide phosphodiesterase (CaMPDE) regulates a large variety of cellular functions and excessive levels of CaM and CaMPDE play important roles in many physiological conditions, symptoms of cardiovascular disease among them. Recently, food derived peptides capable to inhibit CaMPDE have been reported, flaxseed and pea protein derived peptides among them [125, 133, 178]. Oxidative stress is a crucial causative factor for the initiation and progression of hypertension and CVD. Increased production of ROS, such as H2O2 and superoxide anion, reduced NO synthesis, and decreased bioavailability of antioxidants have been demonstrated in experimental and human hypertension. Diet rich in antioxidants can reduce blood pressure and thus, antioxidant properties of food-derived peptides may also affect on blood pressure regulation [180, 181]. Several food derived peptides have been reported to possess dual (ACE-inhibition and antioxidant) activity, among them plant protein derived hydrolysates of flaxseed [44, 55,182], rapeseed [47], potato [13] and yam [115, 116].
New mechanisms of action of antihypertensive peptides have been demonstrated in the recent years. The antihypertensive effect of a rapeseed derived tri-peptide rapakinin, was suggested to be mediated through other mechanism than ACE-inhibition [125]. Later on, different mechanisms were considered and the vasorelaxing activity of rapakinin was not blocked by eNOS inhibitor, while antagonists of IP and CCK1 receptor blocked the vasorelaxing effect of rapakinin significantly [128]. The results demonstrated that rapakinin relaxes the mesenteric artery of SHR through the PGI2-IP receptor followed by CCK pathway and the antihypertensive activity is mediated mainly by the PGI2-IP CCK-CCK1 receptor-dependent vasorelaxation. Moreover, inhibition of platelet-activating factor acetylhydrolase (PAF-AH) is suggested to play a crucial role in the hypertension prevention. PAF-AH is a circulatory enzyme secreted by inflammatory cells and it is involved in atherosclerosis. The discovery and application of natural PAF-AH into health promoting foods open up considerable potential [183].
5. General conclusions
The interest on foods possessing health-promoting or disease-preventing properties has been increasing. So far most of the studies on antihypertensive peptides have been done on milk protein-derived peptides. In fact, much work has been done with dietary antihypertensive peptides and evidence of their effect in animal and clinical studies. However, it has been highlighted that there is a huge potential for obtaining antihypertensive peptides from protein sources other than milk. Much work has been done on plant protein hydrolysates and their activity
Certain aspects, such as identification of the active form of the peptides in the organism and the different mechanisms of action that contribute in the antihypertensive effect still need to be further investigated. Recent advances on specific analytical techniques enable to follow small amounts of the peptides or derivatives in complex matrices and biological fluids. This will allow performing the kinetic studies in model animals and humans. Similarly, identifying novel and more complex biomarkers of exposure and activity by advances in new disciplines such as nutrigenomic and nutrigenetic will open new ways to follow bioactivity in the organism. There is still poor knowledge on the resistance of peptides to gastric degradation, and low bioavailability of peptides has been observed. This reinforces the need of various strategies to improve the oral bioavailability of peptides.
More emphasis has been put on the legal regulation of the health claims attached to the products. Systematic approaches for review and assessment of scientific data have been developed by authorities around the world. The scientific evidence on the beneficial effects of the product should be enough detailed, extensive and conclusive for the use of a health claim in the functional food product labeling and marketing. First, it is necessary to identify and quantify the active sequences in the product. It is mandatory to monitor the hydrolytic or fermentative industrial production process as the antihypertensive peptides are only minor constituents in highly complex food matrices. Second, the antihypertensive effect in humans as well as the minimal dose needed to show the effect has to be proven in extensive investigations to fulfill the requirements of the legislation concerning functional foods. Besides being based on generally accepted scientific evidence, the claims should be well understood by the average consumer. Japan is the pioneer in the area of regulation of the health claims concerning food products. The concept of Foods for Specified Health Use (FOSHU) was established in 1991. In EU, the European Regulation on nutrition and health claims was established in January 2007 and the regulations are governed by European Food Safety Authority (EFSA).
References
- 1.
World Health Organisation ( Fact sheet N°317.2011 Cardiovascular Diseases (CVD’s) - 2.
Lavoie J. L Sigmund C. D 2003 Minireview: Overview of the renin-angiotensin system- An endocrine and paracrine system. Endocrinol.144 2179 2189 - 3.
Landmesser U Spiekermann S Dikalov S Tatge H Wilke R Kohler C Harrison D. G Hornig B Drexler H 2002 Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure- Role of xanthine-oxidase and extracellular superoxide dismutase. Circulation106 3073 3078 - 4.
Yao E. H Yu Y Fukuda N 2006 Oxidative stress on progenitor and stem cells in cardiovascular diseases. Curr. pharm. biotechnol.7 101 108 - 5.
Pihlanto A Korhonen H 2003 Bioactive peptides and proteins. Adv. food res.47 175 276 - 6.
Guang C Phillips R. D 2009 Plant food-derived angiotensin I converting enzyme peptides. J. agric. food chem.57 5113 5120 - 7.
Pihlanto A Mäkinen S Mattila P 2012 Potential health-promoting properties of potato-derived proteins, peptides and phenolic Compounds. In: Caprara C, editor. Potatoes: Production, Consumption and Health Benefits. Nova Publishers173 194 - 8.
Heibges A Salamini F Gebhardt C 2003 Functional comparison of homologous members of three groups of Kunitz-type enzyme inhibitors from potato tubers (Solanum tuberosum L.). Mol. gen. genet.269 535 541 - 9.
Kim J-Y Park C-S Hwang I Cheong H Nah J-W Hahm K-S Park Y 2009 Protease inhibitors from plants with antimicrobial activity. Int. j. mol. sci.10 2860 2872 - 10.
Scherer GFE Ryu SB, Wang XM, Matos AR, Heitz T (2010 Patatin-related phospholipase A: nomenclature, subfamilies and functions in plants. Trends plant sci.15 693 700 - 11.
Bauw G Nielsen H. V Emmersen J Nielsen K. L Jorgensen M Welinder K. G 2006 Patatins, Kunitz protease inhibitors and other major proteins in tuber of potato cv. Kuras FEBS J.273 3569 3584 - 12.
Liu Y. W Han C. H Lee M. H Hsu F. L Hou W. C 2003 Patatin, the tuber storage protein of potato (Solanum tuberosum L.), exhibits antioxidant activity in vitro. J. agric. food chem.51 4389 4393 - 13.
Pihlanto A Akkanen S Korhonen H. J 2008 ACE-inhibitory and antioxidant properties of potato (Solanum tuberosum) Food chem.109 104 112 - 14.
Cheng Y Xiong Y. L Chen J 2010 Fractionation, separation, and identification of antioxidative peptides in potato protein hydrolysate that enhance oxidative stability of soybean oil emulsions. J. food sci.75: C760 C765. - 15.
Hill A. J Peikin S. R Ryan C. A Blundell J. E 1990 Oral administration of proteinase inhibitor II from potatoes reduces energy intake in man. Physiol. behave.48 241 246 - 16.
Bos C Airinei G Mariotti F Benamouzig R Bérot S Evrard J Fénart E Tomé D Gaudichon C 2007 The poor digestibility of rapeseed protein is balanced by its very high metabolic utilization in humans. J. nutr.137 594 600 - 17.
Mariotti F Hermier D Sarrat C Magné J Fenart E Evrard J Tome D Huneau J. F 2008 Rapeseed protein inhibits the initiation of insulin resistance by a high-saturated fat, high-sucrose diet in rats. Br. j. nutr.100 984 991 - 18.
Ooman D. B 2001 Flaxseed as a functional food source. J. sci. food agric.81 889 894 - 19.
( ,Bazzano LA ,He J ,Ogden LG ,Loria C ,Vupputuri S ,Myers L Whelton PK 2001 ) Legume consumption and risk of coronary heart disease in US men and women. Arch. intern. med.161 2573 2578 . - 20.
of the effect of soy protein supplementation on serum lipids. Am j. cardiol.Reynolds K Chin A Lees K. A Nguyen A Bujnowski D He J 2006 A Meta-analysis 98 633 640 - 21.
Gibbs B. F Zougman A Masse R Mulligan C 2004 Production and characterization of bioactive peptides from soy hydrolysate and soy-fermented. Foo d res. int.37 123 131 - 22.
Zhang J. H Tatsumi E Ding C. H Li L. T 2006 Angiotensin I-converting enzyme inhibitory peptides in Douchi, a Chinese traditional fermented soybean product Food chem.98 551 557 - 23.
Fan J Hu X Tan S Zhang Y Tatsumi E Li L 2009 Isolation and characterisation of a novel angiotensin I-converting enzyme-inhibitory peptide derived from douchi, a traditional Chinese fermented soybean food J. sci. food agric.89 603 608 - 24.
Ibe S Yoshida K Kumada K Tsurushin S Furusho T Otobe K 2009 Antihypertensive effects of natto, a traditional Japanese fermented food, in spontaneously hypertensive rats Food sci. technol. res.15 199 202 - 25.
Roy F Boye J. I Simpson B. K 2010 Bioactive proteins and peptides in pulse crops: Pea, chickpea and lentil Food res. int.43 432 442 - 26.
Aluko R. E 2008 Determination of nutritional and bioactive properties of peptides in enzymatic pea, chickpea, and mung bean protein hydrolysates. J. AOAC int.91 947 956 - 27.
Tri Vuong, Duarte J, Aluko RE, Matar C (Ndiaye F 2012 Anti-oxidant, anti-inflammatory and immunomodulating properties of an enzymatic protein hydrolysate from yellow field pea seeds. Eur. j. nutr.51 29 37 - 28.
Arcan I Yemenicioglu A 2010 Effects of controlled pepsin hydrolysis on antioxidant potential and fractional changes of chickpea proteins Food res. int.43 140 147 - 29.
Shewry P. R Halford N. G 2002 Cereal seed storage proteins: structures, properties and role in grain utilization. J. exp. bot.53 947 958 - 30.
Silano M De Vincenzi M 1999 Bioactive antinutritional peptides derived from cereal prolamins: a review. Nahrung43 175 184 - 31.
Miyoshi S Ishikawa H Kaneko T Fukui F Tanaka H Maruyama S 1991 Structures and activity of angiotensin-converting enzyme inhibitors in an alpha-zein hydrolysate. Agric. biol. chem.55 1313 1318 - 32.
Kong X Zhou H Hua Y Qian H 2008 Preparation of wheat gluten hydrolysates with high opioid activity Eur. food res. technol.227 511 517 - 33.
Takahashi M Moriguchi S Yoshikawa M Sakasaki R 1994 Isolation and characterization of oryzatensin- a novel bioactive peptide with ileum-contracting and immunomodulating activities derived from rice albumin. Biochem. mol. biol. int.33 1151 1158 - 34.
Calderón de la Barca AM RuizSalazar RA, JaraMarini ME (2000 Enzymatic hydrolysis of soy protein to improve its amino acid composition and functional properties. J. food sci. 65 246 253 - 35.
Moure A Domínguez H Parajó J. C 2005 Fractionation and enzymatic hydrolysis of soluble protein present in waste liquors from soy processing. J. agric. food chem.53 7600 7608 - 36.
Yim M. H Lee J. H 2000 Functional properties of fractionated soy protein isolates by proteases from Meju Food sci. biotechnol.9 253 257 - 37.
Kristinsson H. G Rasco B. A 2000 Biochemical and functional properties of Atlantic salmon (Salmo salar) muscle hydrolyzed with various alkaline proteases. J. agric food chem.48 657 666 - 38.
Inouye K Nakano K Asaoka K Yasukawa K 2009 Effects of thermal treatment on the coagulation of soy proteins induced by subtilisin Carlsberg J agric. food chem.57 717 23 - 39.
Wu J Ding X 2002 Characterization of inhibition and stability of soy-protein-derived angiotensin I-converting enzyme inhibitory peptides Food res. int.35 367 375 - 40.
Barbana C Boye J. I 2010 Angiotensin I-converting enzyme inhibitory activity of chickpea and pea protein hydrolysates Food res. int.43 1642 1649 - 41.
Pedroche J Yust M. M Giron-calle J Alaiz M Millan F Vioque J 2002 Utilisation of chickpea protein isolates for production of peptides with angiotensin I-converting enzyme (ACE)-inhibitory activity. J. sci. food. agric.82 960 965 - 42.
Udenigwe C. C Aluko R. E 2010 Antioxidant and angiotensin converting enzyme-inhibitory properties of a flaxseed protein-derived high fischer ratio peptide mixture. J. agric. food chem.58 4762 4768 - 43.
Yust M. M Pedroche J Giron-calle J Alaiz M Francisco M Vioque J 2003 Production of ace inhibitory peptides by digestion of chickpea legumin with alcalase. Food chem.81 363 369 - 44.
Udenigwe C. C Adebiyi A. P Doyen A Li H Bazinet L Aluko R. E 2012 Low molecular weight flaxseed protein-derived arginine-containing peptides reduced blood pressure of spontaneously hypertensive rats faster than amino acid form of arginine and native flaxseed protein. Food chem.132 468 475 - 45.
Yust MDM, Alaiz M, Giron-Calle J, Millan F, Vioque J (Megias C Pedroche J 2006 Affinity purification of angiotensin converting enzyme inhibitory peptides using immobilized ACE. J. agric. food chem.54 7120 7124 - 46.
Wu J Aluko R. E Muir A. D 2008 Purification of angiotensin I-converting enzyme-inhibitory peptides from the enzymatic hydrolysate of defatted canola meal. Food chem.111 942 950 - 47.
Mäkinen S Johansson T Vegarud G Pihlava J-M Pihlanto A 2012 Angiotensin I-converting enzyme inhibitory and antioxidant properties of rapeseed hydrolysates. J. funct. foods4 575 583 - 48.
Li G Shi Y Liu H Le G 2006 Antihypertensive effect of alcalase generated mung bean protein hydrolysates in spontaneously hypertensive rats. Eur. food res. technol.222 733 736 - 49.
FitzGerald R Meisel H (2000 Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br. j. nutr. 84: S33 S37. - 50.
Valkonen JPT (Makinen S Kelloniemi J Pihlanto A Makinen K Korhonen H Hopia A 2008 Inhibition of angiotensin converting enzyme I caused by autolysis of potato proteins by enzymatic activities confined to different parts of the potato tuber. J. agric. food chem.56 9875 9883 - 51.
Pena-ramos E. A Xiong Y. L 2002 Antioxidant activity of soy protein hydrolyzates in a liposomial system. J. food sci.67 2952 2956 - 52.
Li Y Jiang B Zhang T Mu W Liu J 2008 Antioxidant and free radical scavenging activities of chickpea protein hydrolysate (CPH). Food chem.106 444 450 - 53.
Korhonen HJT (Dryakova A Pihlanto A Marnila P Curda L 2010 Antioxidant properties of whey protein hydrolysates as measured by three methods. Eur. food res. technol.230 865 874 - 54.
Xia Y Bamdad F Gänzle M Chen L 2012 Fractionation and characterization of antioxidant peptides derived from barley glutelin by enzymatic hydrolysis. Food chem.134 1509 1518 - 55.
Udenigwe C. C Lu Y Han C Hou W Aluko R. E 2009 Flaxseed protein-derived peptide fractions: Antioxidant properties and inhibition of lipopolysaccharide-induced nitric oxide production in murine macrophages. Food chem.116 277 284 - 56.
Suetsuna K Chen J. R 2002 Isolation and characterization of peptides with antioxidant activity derived from wheat gluten. Food sci. tehnol. res.8 227 230 - 57.
Zhang T Li Y Miao M Jiang B 2011 Purification and characterisation of a new antioxidant peptide from chickpea (Cicer arietium L.) protein hydrolysates. Food chem.128 28 33 - 58.
Vermeirssen V Van Camp J Verstraete A Verstraete W 2004 Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br. j. nutr. 92: 357. - 59.
Li C Matsui T Matsumoto K Yamasaki R Kawasaki T 2002 Latent production of angiotensin I-converting enzyme inhibitors from buckwheat protein. J. pept. sci.8 267 274 - 60.
Lo WMY Li-Chan ECY (2005 Angiotensin I converting enzyme inhibitory peptides from in vitro pepsin-pancreatin digestion of soy protein. J. agric. food chem.53 3369 3376 - 61.
Megías C Yust M. M Pedroche J Lquari H Girón-calle J Alaiz M Millán F Vioque J 2004 Purification of an ACE inhibitory peptide after hydrolysis of sunflower (Helianthus annuus L.) protein isolates. J. agric. food chem.52 1928 1932 - 62.
Vermeirssen V Van Der Bent A Van Camp J Van Amerongen A Verstraete W 2004 A quantitative in silico analysis calculates the angiotensin I converting enzyme (ACE) inhibitory activity in pea and whey protein digests. Biochimie86 231 239 - 63.
Boye J. I Roufik S Pesta N Barbana C 2010 Angiotensin I-converting enzyme inhibitory properties and SDS-PAGE of red lentil protein hydrolysates. LWT- Food sci. technol.43 987 991 - 64.
Barbana C Boye J. I 2011 Angiotensin I-converting enzyme inhibitory properties of lentil protein hydrolysates: Determination of the kinetics of inhibition. Food chem.127 94 101 - 65.
Mannheim A Cheryan M 1990 Continuous hydrolysis of milk protein in a membrane reactor. J. food sci.55 381 385 - 66.
Wang Y-K He H-L Wang G-F Wu H Zhou B-C Chen X-L Zhang Y. Z 2010 Oyster (Crassostrea gigas) hydrolysates produced on a plant scale have antitumor activity and immunostimulating effects in BALB/c mice. Mar. drugs8 255 68 - 67.
Chiang W. E Cordle C. T Thomas R. L 1995 Casein hydrolysate produced using a formed-in-place membrane reactor. J. food sci.60 1349 1352 - 68.
Guérard F 2007 Enzymatic methods for marine by-products recovery. In: Shahidi F editor. Maximizing the value of marine by-products. Campridge: Woodward Publishing Limited107 143 - 69.
Chiang W. D Tsou M. J Tsai Z. Y Tsai T. C 2006 Angiotensin I-converting enzyme inhibitor derived from soy protein hydrolysate and produced by using membrane reactor. Food chem.98 725 732 - 70.
Korhonen H Pihlanto A 2003 Food-derived bioactive peptides- Opportunities for designing future foods. Curr. pharm. design9 1297 1308 - 71.
Virtanen T Pihlanto A Akkanen S Korhonen H 2007 Development of antioxidant activity in milk whey during fermentation with lactic acid bacteria. J. appl. microbiol.102 106 115 - 72.
Pihlanto A Virtanen T Korhonen H 2010 Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effect of fermented milk. Int. dairy j.20 3 10 - 73.
Hernández-ledesma B Miralles B Amigo L Ramos M Recio I 2005 Identification of antioxidant and ACE-inhibitory peptides in fermented milk. J. sci. food agric.85 1041 1048 - 74.
Pihlanto A Johansson T Mäkinen S 2012 Inhibition of angiotensin I-converting enzyme and lipid peroxidation by fermented rapeseed and flaxseed meal. Eng. life sci.DOI: elsc.201100137. - 75.
Okamoto A Hanagata H Matsumoto E Kawamura Y Koizumi Y Yanagida F 1995 Angiotensin I-converting enzyme inhibitory peptides isolated from tofuyo fermented soybean food. Biosci. biotech. biochem59 1147 1149 - 76.
Kuba M Tanaka K Tawata S Takeda Y Yasuda M 2003 Angiotensin I-converting enzyme inhibitory peptides isolated from tofuyo fermented soybean food. Biosci. biotech. biochem.67 1278 1283 - 77.
Li F-J Yin L-J Cheng Y-Q Saito M Yamaki K Li L-T 2010 Angiotensin I-converting enzyme inhibitory activities of extracts from commercial chinese style fermented soypaste. JARQ44 167 172 - 78.
Tsai J. S Lin Y. S Pan B. S Chen T. J 2006 Antihypertensive peptides and γ-aminobutyric acid from prozyme 6 facilitated lactic acid bacteria fermentation of soymilk. Process biochem.41 1282 1288 - 79.
Iwai K Nakaya N Kawasaki Y Matsue H 2002 Inhibitory effect of natto, a kind of fermented soybeans, on LDL oxidation in vitro. J. agric. food chem.50 3592 3596 - 80.
Wang D Wang L Zhu F Zhu J Chen X. D Zou L Saito M Li L 2008 In vitro and in vivo studies on the antioxidant activities of the aqueous extracts of Douchi (a traditional Chinese salt-fermented soybean food). Food chem.107 1421 1428 - 81.
Schwager SLU, Sturrock ED, Acharya KR (Natesh R 2003 Crystal structure of the human angiotensin-converting enzyme lisonopril complex. Nature421 551 554 - 82.
Ondetti M. A Rubin B Cushman D. W 1977 Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science196 441 444 - 83.
Cheung H. S Wang F. L Ondetti M. A Sabo E. F Cushman D. W 1980 Binding of peptide substrates and inhibitors of angiotensin-converting enzyme: importance of the COOH-terminal dipeptide sequence. J biol. chem.255 401 407 - 84.
Ariyoshi Y 1993 Angiotensin-converting enzyme inhibitors derived from food proteins. Trends food sci. technol.4 139 144 - 85.
Pripp A. H Isaksson T Stepaniak L Sorhaug T 2004 Quantitative structure-activity relationship modelling of ACE-inhibitory peptides derived from milk proteins. Eur. food res. technol.219 579 583 - 86.
Moure A Domínguez H Parajó J. C 2006 Antioxidant properties of ultrafiltration recovered soy protein fractions from industrial effluents and their hydrolysates. Process biochem.41 447 456 - 87.
Rajapakse N Mendis E Jung W. K Je J. Y Kim S. K 2005 Purification of a radical scavenging peptide from fermented mussel sauce and its antioxidant properties. Food res. int.38 175 182 - 88.
Cheung BWY, Schröder H (Erdmann K 2008 The possible roles of food derived bioactive peptides in reducing the risk of cardiovascular disease. J. nutr. biol.19 643 654 - 89.
Chen H. M Muramoto K Yamauchi F Fujimoto K Nokihara K 1998 Antioxidative properties of histidine-containing peptides designed from peptide fragments found in the digests of a soybean protein. J. agric. food chem.46 49 53 - 90.
Pihlanto A 2006 Antioxidative peptides derived from milk proteins. Int. dairy j.16 1306 1314 - 91.
Chan K. M Decker E. A 1994 Endogenous muscle antioxidants. Crit. rev. food. sci.34 403 426 - 92.
Qian Z. J Jung W. K Kim S. K 2008 Free radical scavenging activity of a novel antioxidative peptide purified from hydrolysate of bullfrog skin, Rana catesbeiana Shaw. bioresource technol.99 1690 1698 - 93.
Chen H. M Muramoto K Yamauchi F Nokihara K 1996 Antioxidant activity of designed peptides based on the antioxidative peptide isolated from digests of a soybean protein. J. agric. food chem.44 2619 2623 - 94.
Saito K Jin D. H Ogawa T Muramoto K Hatakeyama E Yasuhara T Nokihara K 2003 Antioxidative properties of tripeptide libraries prepared by the combinatorial chemistry. J. agric. food chem.51 3668 3674 - 95.
Nagasawa T Yonekura T Nishizawa N Kitts D. D 2001 In vitro and in vivo inhibition of muscle lipid and protein oxidation by carnosine. Mol. cell. biochem.225 29 34 - 96.
Hernández-ledesma B Davalos A Bartolome B Amigo L 2005 Preparation of antioxidant enzymatic hydrolysates from a-lactalbumin and b-lactoglobulin. Identification of active peptides by HPLC-MS/MS. J. agric. food chem.53 588 593 - 97.
Cushman D. W Cheung H. S 1971 Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung. Biochem. pharmacol. 20: 1637. - 98.
Vermeirssen V Van Camp J Verstraete W 2002 Optimisation and validation of an angiotensin-converting enzyme inhibition assay for the screening of bioactive peptides. J. biochem. biophys. methods 51: 75. - 99.
Li G. H Liu H Shi Y-H Le G. W 2005 Direct spectrophotometric measurement of angiotensin I-converting enzyme inhibitory activity for screening bioactive peptides. J. pharm. biomed. anal. 37: 219. - 100.
Shalaby S. M Zakora M Otte J 2006 Performance of two commonly used angiotensin-converting enzyme inhibition assays using synthetic peptide substrates. J. dairy res. 73: 178. - 101.
Doig M. T Smiley J. W 1993 Direct injection assay of angiotensin-converting enzyme by high-performance liquid-chromatography using a shielded hydrophobic phase column. J. chrom. biomed. appl. 613: 145. - 102.
Hyun C Shin H 2000 Utilization of bovine blood plasma proteins for the production of angiotensin I converting enzyme inhibitory peptides, Process biochem.36 65 71 - 103.
Holmquist B Bunning P Riordan J 1979 Continuous spectrophotometric assay for angiotensin converting enzyme. Anal. biochem.95 540 548 - 104.
Carmel A Yaron A 1978 An intramolecularly quenched fuorescent tripeptide as a fuorogenic substrate of angiotensin-I-converting enzyme and of bacterial dipeptidyl carboxypeptidase. Eur. j. biochem. 87: 265. - 105.
simple and sensitive fuorescence method for the assay of angiotensin-I converting enzyme. Food chem. 97: 546.Sentandreu M. A Toldrá F 2006 A Rapid - 106.
Cao G Prior R. L 1998 Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin. chem.44 1309 1315 - 107.
Re R Pellegrini N Proteggente A Pannala A Yang M Rice- Evans C 1999 Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free radical bio. med.26 1231 1237 - 108.
Verma S Buchanan M. R Anderson T. J 2003 Endothelial function testing as a biomarker of vascular disease. Circulation108 2054 9 - 109.
Liu R. H Finley J 2005 Potential cell culture models for antioxidant research. J. agric. food chem.53 4311 4314 - 110.
Elisia I Kitts D. D 2008 Anthocyanins inhibit peroxy radical-induced apoptosis in Caco-2 cells. Mol. cell. biochem.312 139 145 - 111.
Wolfe K. L Liu R. H 2007 Cellular antioxidant activity (CAA) assay for assessing antioxidants, foods, and dietary supplements. J. agric. food chem..55 8896 8907 - 112.
Fitzgerald R. J Murray B. A Walsh D. J 2004 Hypotensive peptides from milk proteins. J. nutr.134 980 988 - 113.
Hsu F Lin Y Lee M Lin C Hou W 2002 Both dioscorin, the tuber storage protein of yam (Dioscorea alata cv. Tainong1 and its peptic hydrolysates exhibited angiotensin converting enzyme inhibitory activities. J. agric. food chem.50 6109 6113 - 114.
Lee M Lin Y Lin Y Hsu F Hou W 2003 The mucilage of yam (Dioscorea batatas Decne) tuber exhibited angiotensin converting enzyme inhibitory activities. Bot. bull. acad. sinica44 267 273 - 115.
Nagai T Suzuki N Nagashima T 2007 Autolysate and enzymatic hydrolysates from yam (Dioscorea opposita Thunb.) tuber mucilage tororo have antioxidant and angiotensin I-converting enzyme inhibitory activities. J. food agric. environ.5 39 43 - 116.
Nagai T Suzuki N Tanoue Y Kai N Nagashima T 2007 Antioxidant and antihypertensive activities of autolysate and enzymatic hydrolysates from yam (Dioscorea opposita Thunb.) ichyoimo tubers. J. food agric. environ.5 64 68 - 117.
Lacaille-dubois M. A Franck U Wagner H 2001 Search for potential angiotensin converting enzyme (ACE)-inhibitors from plants. Phytomedicine8 47 52 - 118.
Huang G Lu T Chiu C Chen H Wu C Lin Y Hsieh W Liao J Sheu M Lin Y 2011 Sweet potato storage root defensin and its tryptic hydrolysates exhibited angiotensin converting enzyme inhibitory activity in vitro. Bot. stud.52 257 264 - 119.
Huang G Chen H Susumu K Wu J Hou W Wu C Sheu M Huang S Lin Y 2011 Sweet potato storage root thioredoxin h2 and their peptic hydrolysates exhibited angiotensin converting enzyme inhibitory activity in vitro. Bot. stud.52 15 22 - 120.
Huang G Ho Y Chen H Chang Y Huang S Hung H Lin Y 2008 Sweet potato storage root trypsin inhibitor and their peptic hydrolysates exhibited angiotensin converting enzyme inhibitory activity in vitro. Bot. stud.49 101 108 - 121.
Ishiguro K Sameshima Y Kume T Ikeda K Matsumoto J Yoshimoto M 2012 Hypotensive effect of a sweet potato protein digest in spontaneously hypertensive rats and purification of angiotensin I-converting enzyme inhibitory peptides. Food chem.131 774 779 - 122.
Lin C Lin S Lin Y Hou W 2006 Effects of tuber storage protein of yam (Dioscorea alata cv. Tainong1 and its peptic hydrolyzates on spontaneously hypertensive rats. J. sci. food agric.86 1489 1494 - 123.
Liu Y Lin Y Liu D Han C Chen C Fan M Hou W 2009 Effects of different types of yam (Dioscorea alata) products on the blood pressure of spontaneously hypertensive Rats. Biosci. biotech. biochem.73 1371 1376 - 124.
Iwai K Matsue H 2007 Ingestion of Apios americana Medikus tuber suppresses blood pressure and improves plasma lipids in spontaneously hypertensive rats. Nutr. res.27 218 224 - 125.
Marczak E Usui H Fujita H Yang Y Yokoo M Lipkowski A Yoshikawa M 2003 New antihypertensive peptides isolated from rapeseed. Peptides24 791 798 - 126.
Udenigwe C. C Lin Y. S Hou W. C Aluko R. E 2009 Kinetics of the inhibition of renin and angiotensin I-converting enzyme by flaxseed protein hydrolysate fractions. J. funct. foods1 199 207 - 127.
Wanasundara, JPD (Marambe H. K Shand P. J 2011 Release of angiotensin I-converting enzyme inhibitory peptides from flaxseed (Linum usitatissimum L.) protein under simulated gastrointestinal digestion. J. agric. food chem.59 9596 9604 - 128.
Yamada Y Iwasaki M Usui H Ohinata K Marczak E. D Lipkowski A. W Yoshikawa M 2010 Rapakinin, an anti-hypertensive peptide derived from rapeseed protein, dilates mesenteric artery of spontaneously hypertensive rats via the prostaglandin IP receptor followed by CCK1 receptor. Peptides31 909 914 - 129.
Marczak E. D Ohinata K Lipkowski A. W Yoshikawa M 2006 Arg-Ile-Tyr (RIY) derived from rapeseed protein decreases food intake and gastric emptying after oral administration in mice. Peptides27 2065 2068 - 130.
Yamada Y Ohinata K Lipkowski A. W Yoshikawa M 2011 Rapakinin, Arg-Ile-Tyr, derived from rapeseed napin, shows anti-opioid activity via the prostaglandin IP receptor followed by the cholecystokinin CCK2 receptor in mice. Peptides 32:281 285 - 131.
Akillioglu H. G Karakaya S 2009 Effects of heat treatment and in vitro digestion on the angiotensin converting enzyme inhibitory activity of some legume species. Eur. food res. technol.229 915 921 - 132.
Vermeirssen V Van Camp J Decroos K Van Wijmelbeke L Verstraete W 2003 The impact of fermentation and in vitro digestion on the formation of angiotensin-I-converting enzyme Inhibitory activity from pea and whey protein. J. dairy. sci.86 429 438 - 133.
Li H Aluko R. F 2010 Identification and inhibitory properties of multifunctional peptides from pea protein hydrolysate. J. agric. food chem.58 11471 11476 - 134.
Lo WMY Farnworth ER, Li-Chan ECY (2006 Angiotensin I-converting enzyme inhibitory activity of soy protein digests in a dynamic model system simulating the upper gastrointestinal tract. J. food. sci. 71: S231 S237. - 135.
Pownall T. L Udenigwe C. C Aluko R. E 2010 Amino acid composition and antioxidant properties of pea seed (Pisum sativum L.) enzymatic protein hydrolysate fractions. J. agric. food chem.58 4712 4718 - 136.
Pownall T. L Udenigwe C. C Aluko R. E 2011 Effects of cationic property on thein vitro antioxidant activities of pea protein hydrolysate fractions. Food res. int.44 1069 1074 - 137.
Li Y Jiang B Zhang T Mu W Liu J 2008 Antioxidant and free radical-scavenging activities of chickpea protein hydrolysate (CPH). Food chem.106 444 450 - 138.
Liu J. R Chen M. J Lin C. W 2005 Antimutagenic and antioxidant properties of milk-kefir and soymilk-kefir. J. agric. food chem53 2467 2474 - 139.
Zhang L Lia J Zhoub K 2010 Chelating and radical scavenging activities of soy protein hydrolysates prepared from microbial proteases and their effect on meat lipid peroxidation. Bioresource technology,101 2084 2089 - 140.
Chen H. M Muramoto K Yamauchi F 1995 Structural analysis of antioxidant peptides from soybean b-conglycinin. J Agric Food Chem43 574 578 - 141.
Park S. Y Lee J. S Baek H. H Lee H. G 2010 Purification and characterization of antioxidant peptides from soy protein hydrolysate. J. food biochem.34 120 134 - 142.
Hsu G. W Lu Y Chang S Hsu S 2011 Antihypertensive effect of mung bean sprout extracts in spontaneously hypertensive rats. J. food biochem.35 278 288 - 143.
Jones PJH, Aluko RE (Li H Prairie N Udenigwe C. C Adebiyi A. P Tappia P. S Aukema H. M 2011 Blood pressure lowering effect of a pea protein hydrolysate in hypertensive rats and humans. J. agric. food chem.59 9854 9860 - 144.
Vermeirssen V Augustijns P Morel N Van Camp J Opsomer A Verstraete W 2005 In vitro intestinal transport and antihypertensive activity of ACE inhibitory pea and whey digests. Int. j. food sci. nutr.56 415 430 - 145.
Lee N. Y Kim Y Choi I Cho S Hyun J Choi J Park K Kim K Lee M 2010 Biological activity of barley (Hordeum vulgare L.) and barley byproduct extracts. Food sci. biotechnol.19 785 791 - 146.
Aludatt M. H Ereifej K Abou-zaitoun A Al-rababah M Almajwal A Rababeh T Yang W 2012 Oxidant, anti-diabetic and anti-hypertensive effects of extracted phenolics and hydrolyzed peptides from barley protein fraction. Int. j. food prop.15 781 795 - 147.
Iwaniak A Dziuba B 2009 Motifs with potential physiological activity in food proteins-Biopep database. Acta Scientiarum Polonorum: Technologia Alimentaria8 59 85 - 148.
Ying Hu Stromeck A, Loponen J, Lopes-Lutz D, Schieber A, Gänzle MG (2011 LC-MS/MS Quantification of bioactive angiotensin I-converting enzyme inhibitory peptides in rye malt sourdoughs. J. agric. food chem.59 11983 11989 - 149.
Cheung IWY Nakayama S, Hsu MNK, Samaranayaka AGP, Li-Chan ECY (2009 Angiotensin-I converting enzyme inhibitory activity of hydrolysates from oat (Avena sativa) proteins by in silico and in vitro analyses. J agric. food chem.57 9234 9242 - 150.
Kong X Zhou H Hua Y 2008 Preparation and antioxidant activity of wheat gluten hydrolysates (WGHs) using ultrafiltration membranes. J sci. food agric.88 920 926 - 151.
Zhang J Zhang H Wang L Guo X Wang X Yao H 2010 Isolation and identification of antioxidative peptides from rice endosperm protein enzymatic hydrolysate by consecutive chromatography and MALDI-TOF/TOF MS/MS. Food chem.119 226 234 - 152.
Li G. H Qu M. R Wan J. Z You J. M 2007 Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats. Asia pa. j. clin. nutr.16 275 280 - 153.
Matsui T Li C. H Tanaka T Maki T Osajima Y Matsumoto K 2000 Depressor effect of wheat germ hydrolysate and its novel angiotensin I-converting enzyme inhibitory peptide, Ile-Val-Tyr, and the metabolism in rat and human plasma. Biol. pharm. bull.23 427 431 - 154.
De Leo F Panarese S Gallerani R Ceci L. R 2009 Angiotensin converting enzyme (ACE) inhibitory peptides: production and implementation of functional food. Curr. pharm. design15 3622 3643 - 155.
Eriksen E. K Holm H Jensen E Aaboe R Devold T. G Jacobsen M Vegarud G. E 2010 Different digestion of caprine whey proteins by human and porcine gastrointestinal enzymes. Br. j. nutr.104 374 381 - 156.
Zhu L Chen J Tang X Xiong Y. L 2008 Reducing, radical scavenging, and chelation properties of in vitro digests of alcalase-treated zein hydrolysate. J. agric. food chem.56 2714 2721 - 157.
Gardner MLG ( Annu. rev. nutr.1988 Gastrointestinal absorption of intact proteins8 329 350 - 158.
Gardner MLG ( In: Grimble GK, Backwell FRG, editors. Tissue utilization and clinical targeting. London: Portland Press Ltd.1998 Transmucosal passage on intact peptides in mammalian metabolism - 159.
Shimizu M Tsunogai M Arai S 1997 Transepithelial transport of oligopeptides in the human intestinal cell, Caco2. Peptides18 681 687 - 160.
Duchateau GSMJE, AugustijnsFoltz M Cerstiaens A Van Meensel A Mols R Van Der Pijl P. C 2008 The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models. Peptides 29: 1312-1320. - 161.
Ten Have GA, Duchateau GS, Deutz NE (Van Der Pijl P. C Kies A. K 2008 Pharmacokinetics of proline-rich tripeptides in the pig. Peptides29 2196 2202 - 162.
Koning TMMG, Kloek J (Foltz M Meynen E. E Bianco V Van Platerink C 2007 Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. J. nutr.137 953 958 - 163.
Quiros A Davalos A Lasuncion M. A Ramos M Recio I 2008 Bioavailability of the antihypertensive peptide LHLPLP: Transepithelial flux of HLPLP. Int. dairy j.18 279 286 - 164.
del Mar Contreras M, Ramos M, Amigo L, Recio I (Quiros A 2009 Stability to gastrointestinal enzymes and structure-activity relationship of beta-casein-peptides with antihypertensive properties. Peptides30 1848 1853 - 165.
Van Platerink C Janssen H Horsten R Haverkamp J 2006 Quantification of ACE inhibiting peptides in human plasma using high performance liquid chromatography-mass spectrometry. J. chromatogr. B830 151 157 - 166.
Fujita H Yokoyama K Yoshikawa M 2000 Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins. J. food sci.65 564 569 - 167.
Zhao Y Li B Dong S Liu Z Zhao X Wang J Zeng M 2009 A novel ACE inhibitory peptide isolated from Acaudina molpadioidea hydrolysate. Peptides30 1028 1033 - 168.
Muguruma M Ahhmed A. M Katayama K Kawahara S Maruyama M Nakamura T 2009 Identification of pro-drug type ACE inhibitory peptide sourced from porcine myosin B: Evaluation of its antihypertensive effects in vivo. Food chem.114 516 522 - 169.
Shaji J Patole V 2008 Protein and peptide drug delivery: Oral approaches. J. pharm. sci.70 269 277 - 170.
Kies A. K Van Der Pijl P 2012 Peptide availability. USA Patent Application 20120040895. - 171.
Nestor JJ Jr 2009 The medicinal chemistry of peptides. Curr. med. chem.16 4399 4418 - 172.
Yamada Y Matoba N Usui H Onishi K Yoshikawa M 2002 Design of a highly potent anti-hypertensive peptide based on ovokinin(2-7). Biosci. biotechn. biochem.66 1213 1217 - 173.
Matoba N Yamada Y Usui H Nakagiri R Yoshikawa H 2001 Designing potent derivatives of ovokinin(2-7), an anti-hypertensive peptide derived from ovalbumin. Biosci. biotechn. biochem.65 736 739 - 174.
Gomez-guillen M. C Gimenez B Lopez-caballero M. E Montero M. P 2011 Functional and bioactive properties of collagen and gelatin from alternative sources: A review. Food hydrocolloids25 1813 1827 - 175.
Liu D Liang H Han C Lin S Chen C Fan M Hou W 2009 Feeding trial of instant food containing lyophilised yam powder in hypertensive subjects. J. sci. food agric.89 138 143 - 176.
Peach M. J 1997 Renin-angiotensin system: biochemistry and mechanism of action. Physiol. rev.57 313 370 - 177.
Gradman A Schmieder R Lins R Nussberger J Chiang Y Bedigian M 2005 Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients. Circulation111 1012 1018 - 178.
Udenigwe C. C Aluko R. E 2012 Multifunctional cationic peptide fractions from flaxseed protein hydrolysates. Plant food hum. nutr.67 1 9 - 179.
Erdmann K Grosser N Schipporeit K Schroeder H 2006 The ACE inhibitory dipeptide Met-Tyr diminishes free radical formation in human endothelial cells via induction of heme oxygenase-1 and ferritin. J. nutr.136 2148 2152 - 180.
Touyz R 2004 Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension- What is the clinical significance? Hypertension44 248 252 - 181.
Akpaffiong M Taylor A 1998 Antihypertensive and vasodilator actions of antioxidants in spontaneously hypertensive rats. Am. j. hyp.11 1450 1460 - 182.
Marambe PWMLHK Shand PJ, Wanasundara JPD (2008 An in-vitro investigation of selected biological activities of hydrolysed flaxseed (Linum usitatissimum L.) proteins. J. am. oil chem. soc.85 1155 1164 - 183.
Fitzgerald C Gallagher E Tasdemir D Hayes M 2011 Heart health peptides from macroalgae and their potential use in functional foods. J. agric. food chem.59 6829 6836 - 184.
Nakahara T Sano A Yamaguchi H Sugimoto K Chikata H Kinoshita E Uchida R 2010 Antihypertensive effect of peptide-enriched soy sauce-like seasoning and identification of its angiotensin I-converting enzyme inhibitory substances. J. agric. food chem.58 821 827 - 185.
Nogata Y Nagamine T Sekiya K 2011 Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides derived from wheat bran in spontaneously hypertensive rats. J. jpn. soc. food sci. technol.58 67 70 - 186.
Nogata Y Nagamine T Yanaka M Ohta H 2009 Angiotensin I converting enzyme inhibitory peptides produced by autolysis reactions from wheat bran. J. agric. food chem.57 6618 6622